Even if our previous experiments have demonstrated the superior proliferation capacity of IL-21R-TCR-T upon CD3/CD28 activation, the proportion analysis supported by scRNA-seq data further revealed the phenotype of proliferating T cells after tumor antigen stimulation in detail. The gene discussed is IL21R; the disease is neoplasm.